Total submissions: 7
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Eurofins Ntd Llc |
RCV000489163 | SCV000230064 | pathogenic | not provided | 2014-12-05 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000456500 | SCV000552821 | pathogenic | Charcot-Marie-Tooth disease, type I | 2024-08-06 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 72 of the PMP22 protein (p.Ser72Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Dejerine-Sottas disease and congenital hypomyelinating neuropathy (PMID: 8275092, 9004143, 9585367, 10399754, 11314784). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 8433). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PMP22 protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. |
| Gene |
RCV000489163 | SCV000577163 | pathogenic | not provided | 2022-02-08 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 10399754, 11314784, 9888385, 15285778, 8275092, 21840889, 19748054, 19705173, 31130284, 32005694) |
| Ambry Genetics | RCV000622525 | SCV000742419 | pathogenic | Inborn genetic diseases | 2017-04-24 | criteria provided, single submitter | clinical testing | |
| Laboratory of Medical Genetics, |
RCV001729342 | SCV001976812 | pathogenic | Charcot-Marie-Tooth disease, type IA | 2021-10-05 | criteria provided, single submitter | clinical testing | PM1, PM2, PM5, PP3, PP5 |
| Revvity Omics, |
RCV000489163 | SCV002018871 | pathogenic | not provided | 2020-08-28 | criteria provided, single submitter | clinical testing | |
| OMIM | RCV000008948 | SCV000029158 | pathogenic | DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT | 1998-05-01 | no assertion criteria provided | literature only |